The rapid spread of a sub-variant of COVID-19, known as JN1, is causing concern among U.S. health officials. With almost half of the new cases in the country being attributed to this variant, experts predict that it will soon become the dominant strain globally. Although the current vaccines are expected to provide protection against JN1, its increased ability to evade immunity raises concerns.
Recent data indicates that JN1 is particularly prevalent in the U.S. northeast, highlighting the urgency of addressing this escalating issue. However, the low vaccination rates continue to be a significant challenge. According to the latest data from the Centers for Disease Control and Prevention (CDC), only about 17% of adults and 8% of children have received the most recent COVID-19 shot. Such low rates come as no surprise, given the amount of misinformation circulating and various influencing factors.
